Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ABUS
#2525
Arbutus Biopharma Corporation - Common Stock
4.6
7
USD
-0.03%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-2.71%
Monthly Change
+8.60%
6 month change
-1.89%
Year Change
+44.58%
Previous Close
4.8
0
Open
4.6
7
Low
4.6
7
High
4.6
7
Volume
86
Markets
US Stock Market
Healthcare
Biotechnology
ABUS
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
95.58 M
148.64 M
162.57 M
179.49 M
191.48 M
195.48 M
197.54 M
Valuation ratios
Enterprise value
287.07 M
468.93 M
331.76 M
438.6 M
589.81 M
922.24 M
1.01 B
Price to earnings ratio
—
-4.69
-4.85
-5.89
-8.61
-28.29
6.33
Price to sales ratio
—
37.61
8.63
23.69
98.35
65.44
5.35
Price to cash flow ratio
—
6.12
9.52
5
9.36
-23.25
-29.49
Price to book ratio
—
2.44
2.46
4.05
6.23
12.04
2.05
Enterprise value to EBITDA ratio
-5.12
-6.44
-5.18
-5.56
-7.55
-22.97
6.5
Profitability ratios
Return on assets %
-0.47
-0.37
-0.36
-0.5
-0.53
-0.35
0.61
Return on equity %
-0.63
-0.45
-0.51
-0.69
-0.72
-0.44
0.65
Return on invested capital %
-418.5
-1 084.74
-479.17
-729.1
-1 648.58
-21.53 K
758.4
Gross margin %
100
100
100
100
100
100
100
Operating margin %
-836.07
-669.11
-167.75
-430.53
-1 236.74
-270.96
94.3
EBITDA margin %
-810.5
-662.25
-164.24
-434.9
-1 265.18
-285.07
94.3
Net margin %
-921.97
-693.91
-178.01
-401.57
-1 133.04
-237.88
94.73
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
13.38
14.32
4.6
5.87
8.15
15.73
54.26
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.06
0.06
0.2
0.11
0.04
0.12
0.96
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
0
0
0
0
0
0
Long term debt to total equity ratio
—
0
0
0
0
0
0
Per share metrics
Operating cash flow per share
—
-0.64
-0.23
-0.52
-0.35
-0.21
-0.18
EBIT per share
—
-0.69
-0.43
-0.47
-0.41
-0.2
0.8
EBITDA per share
—
-0.68
-0.42
-0.48
-0.42
-0.21
0.8
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
1.8
1.22
0.8
0.66
0.48
0.49
Net current asset value per share
—
1.51
1
0.8
0.69
0.49
1.42
Tangible book value per share
—
1.59
0.91
0.64
0.52
0.4
1.33
Working capital per share
—
1.41
0.78
0.66
0.6
0.46
1.39
Book value per share
—
1.59
0.91
0.64
0.52
0.4
1.33
News
Arbutus Biopharma: A Fascinating HBV Story, But Still Too Early (NASDAQ:ABUS)
Moderna's Revenues See Strong International Momentum in Q1 Earnings
Moderna's Quarterly Earnings Preview: What You Need to Know
Moderna reaches $950 million settlement with Arbutus and Genevant over patent litigation
Why Moderna’s $950M Patent Bill Is A Small Price For Pipeline Freedom (NASDAQ:MRNA)
Chardan reiterates Arbutus Biopharma stock rating on Moderna deal
MRNA Stock Gains on $2.25B Deal to Settle Patent Dispute With ROIV, ABUS
Moderna rises as up to $2.25 billion settlement for COVID vaccine patent dispute to remove overhang
Moderna shares jump as settlement removes major legal overhang
Stock Market Today: Dow, Nasdaq Higher; Bitcoin Surges On Trump News (Live Coverage)
CrowdStrike, Nvidia and Moderna rise premarket; Abercrombie & Fitch falls
Moderna settles COVID vaccine patent dispute for up to $2.25 billion